Ignite Creation Date:
2024-05-06 @ 2:49 PM
Last Modification Date:
2024-10-26 @ 1:38 PM
Study NCT ID:
NCT04438980
Status:
COMPLETED
Last Update Posted:
2021-05-17
First Post:
2020-06-18
Brief Title:
Glucocorticoids in COVID-19 CORTIVID
Sponsor:
Fundacion Miguel Servet
Organization:
Fundacion Miguel Servet
Study Overview
Official Title:
Treatment of COVID-19 Pneumonia With Glucocorticoids A Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2021-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CORTIVID
Brief Summary:
Around 30 of admitted patients with COVID-19 pneumonia develop a hyper-inflammatory state whose progression to an acute respiratory distress syndrome ARSD could be prevented by the early initiation of immune-modulatory agents The role of glucocorticoids GC in this setting remains controversial This study aims to assess the safety and effectiveness of GC pulses to improve the clinical outcomes of patients with COVID-19 pneumonia with risen inflammatory biomarkers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None